According to the newest analysis by Reports and Data, the global DNA polymerase market is estimated to reach USD 568.3 million in 2030, with a revenue CAGR of 6.4 percent over the forecast period. Consumer demand for customized DNA polymerase and Next-Generation DNA sequencing is likely to drive market revenue growth over the forecast period. Between 2022 and 2030, the market is estimated to be driven by rising demand for DNA polymerase in hospitals, diagnostic centers, and other medical facilities. DNA polymerase is widely employed in tiny quantities in medical and diagnostic institutions for the diagnosis of external viral infections and even genetic diseases via DNA, which is driving up demand.
Additionally, throughout the current pandemic, DNA polymerase has been extensively used in research laboratories to achieve innovative breakthroughs in the disease, increasing its demand. These factors are likely to promote market revenue growth by increasing DNA polymerase adoption. Additionally, increased demand for customized DNA polymerase to enhance its function in reactions of varying temperatures is likely to drive sales growth in the industry.
Some of the Report’s Highlights
- Revenue growth in the pharmaceutical business is predicted to be consistent over the projection period. The category is predicted to rise due to the rising demand for DNA polymerases in hospitals, diagnostic centers, and other medical facilities. DNA polymerase is a necessary enzyme for the polymerization of nucleoside triphosphates, which is another element projected to drive the segment’s revenue growth.
- Over the projection period, the Polymerization Chain Reaction (PCR) segment is predicted to develop at a stable rate. The use of PCR for DNA diagnosis of disease including the use of DNA polymerase is becoming chevalier. Increased use of DNA polymerase in analytic laboratories for detecting the presence of viral illnesses is also predicted to fuel the segment’s growth shortly.
For more insights into the market, Request a Sample Copy
